Encompass Health Co. (NYSE:EHC) Shares Sold by Reinhart Partners LLC.

Reinhart Partners LLC. decreased its position in shares of Encompass Health Co. (NYSE:EHC - Free Report) by 14.2% during the 1st quarter, according to the company in its most recent disclosure with the SEC. The fund owned 562,968 shares of the company's stock after selling 93,352 shares during the quarter. Encompass Health makes up about 2.1% of Reinhart Partners LLC.'s holdings, making the stock its 22nd largest position. Reinhart Partners LLC. owned 0.56% of Encompass Health worth $57,017,000 at the end of the most recent reporting period.

Other hedge funds also recently made changes to their positions in the company. Colonial Trust Co SC purchased a new position in shares of Encompass Health during the fourth quarter worth about $29,000. Transce3nd LLC purchased a new position in shares of Encompass Health during the fourth quarter worth about $40,000. CBIZ Investment Advisory Services LLC grew its holdings in shares of Encompass Health by 38.7% during the fourth quarter. CBIZ Investment Advisory Services LLC now owns 455 shares of the company's stock worth $42,000 after purchasing an additional 127 shares during the last quarter. V Square Quantitative Management LLC grew its holdings in shares of Encompass Health by 43.8% during the fourth quarter. V Square Quantitative Management LLC now owns 581 shares of the company's stock worth $54,000 after purchasing an additional 177 shares during the last quarter. Finally, Signaturefd LLC grew its holdings in shares of Encompass Health by 21.6% during the fourth quarter. Signaturefd LLC now owns 704 shares of the company's stock worth $65,000 after purchasing an additional 125 shares during the last quarter. Hedge funds and other institutional investors own 97.25% of the company's stock.

Analyst Upgrades and Downgrades

Several equities analysts have issued reports on the company. Barclays raised their price objective on Encompass Health from $118.00 to $129.00 and gave the stock an "overweight" rating in a report on Friday, April 25th. William Blair reaffirmed an "outperform" rating on shares of Encompass Health in a research note on Friday, February 7th. Wall Street Zen cut Encompass Health from a "strong-buy" rating to a "buy" rating in a research report on Friday. Stephens reiterated an "overweight" rating and issued a $135.00 target price on shares of Encompass Health in a research note on Thursday. Finally, Truist Financial reiterated a "buy" rating and issued a $135.00 target price (up from $116.00) on shares of Encompass Health in a research note on Monday, April 28th. Nine research analysts have rated the stock with a buy rating and one has given a strong buy rating to the company's stock. Based on data from MarketBeat, Encompass Health presently has an average rating of "Buy" and an average target price of $127.00.

Insider Activity at Encompass Health

In related news, EVP John Patrick Darby sold 10,000 shares of Encompass Health stock in a transaction on Tuesday, April 29th. The stock was sold at an average price of $114.79, for a total transaction of $1,147,900.00. Following the completion of the transaction, the executive vice president now directly owns 79,710 shares of the company's stock, valued at approximately $9,149,910.90. The trade was a 11.15% decrease in their ownership of the stock. The sale was disclosed in a document filed with the SEC, which can be accessed through this link. Also, CEO Mark J. Tarr sold 118,384 shares of Encompass Health stock in a transaction on Tuesday, May 20th. The stock was sold at an average price of $121.53, for a total value of $14,387,207.52. Following the transaction, the chief executive officer now directly owns 527,070 shares of the company's stock, valued at approximately $64,054,817.10. This represents a 18.34% decrease in their ownership of the stock. The disclosure for this sale can be found here. Insiders have sold a total of 132,663 shares of company stock worth $16,034,082 over the last three months. 2.10% of the stock is currently owned by corporate insiders.

Encompass Health Stock Up 0.2%

Encompass Health stock opened at $121.57 on Friday. The company has a debt-to-equity ratio of 0.84, a current ratio of 1.05 and a quick ratio of 1.04. Encompass Health Co. has a 1-year low of $82.74 and a 1-year high of $123.13. The company has a market cap of $12.25 billion, a PE ratio of 27.26, a price-to-earnings-growth ratio of 2.31 and a beta of 0.89. The stock's 50 day moving average price is $111.96 and its 200 day moving average price is $102.74.

Encompass Health (NYSE:EHC - Get Free Report) last posted its quarterly earnings results on Thursday, April 24th. The company reported $1.37 earnings per share for the quarter, beating analysts' consensus estimates of $1.19 by $0.18. Encompass Health had a return on equity of 17.56% and a net margin of 8.48%. The firm had revenue of $1.46 billion for the quarter, compared to the consensus estimate of $1.43 billion. During the same period in the previous year, the business earned $1.12 earnings per share. The company's revenue for the quarter was up 10.6% compared to the same quarter last year. On average, sell-side analysts predict that Encompass Health Co. will post 4.8 EPS for the current fiscal year.

Encompass Health Announces Dividend

The firm also recently declared a quarterly dividend, which will be paid on Tuesday, July 15th. Investors of record on Tuesday, July 1st will be paid a $0.17 dividend. The ex-dividend date of this dividend is Tuesday, July 1st. This represents a $0.68 dividend on an annualized basis and a dividend yield of 0.56%. Encompass Health's dividend payout ratio (DPR) is presently 14.05%.

Encompass Health Profile

Encompass Health Corporation provides post-acute healthcare services in the United States and Puerto Rico. It owns and operates inpatient rehabilitation hospitals that provide medical, nursing, therapy, and ancillary services. The company provides specialized rehabilitative treatment on an inpatient basis to patients who have experienced physical or cognitive disabilities or injuries due to medical conditions, such as strokes, hip fractures, and various debilitating neurological conditions.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.